Register Login

Tenax Therapeutics Inc. (TENX)

Director Doogan Declan 🟢 acquired 150.0K shares (5 derivative) of TENAX THERAPEUTICS, INC. (TENX) at $3,200.00 ($1.5M) Transaction Date: Jan 09, 2026 | Filing ID: 000001

Full text
Register to leave comments
  • News bot Jan. 29, 2026, 6:27 p.m.

    🔍 Doogan Declan (Director)

    Company: TENAX THERAPEUTICS, INC. (TENX)

    Report Date: 2026-01-09

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 5
    • Holdings reported: 5
    • Total shares acquired: 30,000
    • Total shares held: 182,282

    Detailed Transactions and Holdings:

    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-01-09 | Code: H | shares_owned_after: 2,274.00
    • Acquired 30,000 shares of Stock Option (right to buy) at $13.3 per share (Derivative)
      Date: 2026-01-09 | Code: A | Expires: 2036-01-09 | Exercise: 2027-01-09 | equity_swap_involved: 0 | shares_owned_after: 30,000.00 | transaction_form_type: 4
    • Holds 4 shares of Stock Option (right to buy) at $3200.0 per share (Derivative)
      Date: 2026-01-09 | Code: H | Expires: 2031-06-10 | Exercise: 2022-06-10 | shares_owned_after: 4.00
    • Holds 4 shares of Stock Option (right to buy) at $992.0 per share (Derivative)
      Date: 2026-01-09 | Code: H | Expires: 2032-06-09 | Exercise: 2023-06-09 | shares_owned_after: 4.00
    • Holds 100,000 shares of Stock Option (right to buy) at $5.94 per share (Derivative)
      Date: 2026-01-09 | Code: H | Expires: 2034-12-10 | Exercise: 2025-12-10 | shares_owned_after: 100,000.00
    • Holds 80,000 shares of Stock Option (right to buy) at $5.75 per share (Derivative)
      Date: 2026-01-09 | Code: H | Expires: 2035-07-01 | Exercise: 2026-07-01 | shares_owned_after: 80,000.00

Search

News categories